These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Near-Infrared Light-Activated Phototherapy by Gold Nanoclusters for Dispersing Biofilms. Xie Y; Zheng W; Jiang X ACS Appl Mater Interfaces; 2020 Feb; 12(8):9041-9049. PubMed ID: 32011117 [TBL] [Abstract][Full Text] [Related]
11. Validation of the Zürich burn-biofilm model. Guggenheim M; Thurnheer T; Gmür R; Giovanoli P; Guggenheim B Burns; 2011 Nov; 37(7):1125-33. PubMed ID: 21724333 [TBL] [Abstract][Full Text] [Related]
12. Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. Roveta S; Schito AM; Marchese A; Schito GC Int J Antimicrob Agents; 2007 Nov; 30(5):415-21. PubMed ID: 17768034 [TBL] [Abstract][Full Text] [Related]
13. Biofilm formation as microbial development. O'Toole G; Kaplan HB; Kolter R Annu Rev Microbiol; 2000; 54():49-79. PubMed ID: 11018124 [TBL] [Abstract][Full Text] [Related]
14. A novel compound from the marine bacterium Bacillus pumilus S6-15 inhibits biofilm formation in gram-positive and gram-negative species. Nithya C; Devi MG; Karutha Pandian S Biofouling; 2011 May; 27(5):519-28. PubMed ID: 21614700 [TBL] [Abstract][Full Text] [Related]
15. High-throughput screening of metal-N-heterocyclic carbene complexes against biofilm formation by pathogenic bacteria. Bernardi T; Badel S; Mayer P; Groelly J; de Frémont P; Jacques B; Braunstein P; Teyssot ML; Gaulier C; Cisnetti F; Gautier A; Roland S ChemMedChem; 2014 Jun; 9(6):1140-4. PubMed ID: 24729552 [TBL] [Abstract][Full Text] [Related]
16. The effects of tetracycline, minocycline, doxycycline and ofloxacin on Prevotella intermedia biofilm. Takahashi N; Ishihara K; Kimizuka R; Okuda K; Kato T Oral Microbiol Immunol; 2006 Dec; 21(6):366-71. PubMed ID: 17064394 [TBL] [Abstract][Full Text] [Related]
17. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006. Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477 [TBL] [Abstract][Full Text] [Related]
18. The biofilm architecture of sixty opportunistic pathogens deciphered using a high throughput CLSM method. Bridier A; Dubois-Brissonnet F; Boubetra A; Thomas V; Briandet R J Microbiol Methods; 2010 Jul; 82(1):64-70. PubMed ID: 20433880 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates. Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230 [TBL] [Abstract][Full Text] [Related]
20. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Burrowes B; Harper DR; Anderson J; McConville M; Enright MC Expert Rev Anti Infect Ther; 2011 Sep; 9(9):775-85. PubMed ID: 21905786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]